首页> 外文期刊>Pediatric blood & cancer >Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group.
【24h】

Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group.

机译:特发性血小板减少性紫癜儿童的脾切除术:一项来自洲际儿童ITP研究小组的134名儿童的前瞻性研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Splenectomy is an effective procedure for children and adults with severe or refractory idiopathic thrombocytopenic purpura (ITP). Data regarding pediatric patients are limited. PROCEDURE: Sixty-eight Intercontinental Childhood ITP Study Group (ICIS) investigators from 57 institutions in 25 countries participated in a splenectomy registry. Data from 153 patients were submitted, of whom 134 had a splenectomy and were analyzed. RESULTS: The median age at splenectomy was 11.8 (2.7-20.7) years. The median postsplenectomy follow-up was 2.0 (0.1-4.5) years. Pre-splenectomy vaccination was not administered in 21 children (15.7%). Open and laparoscopic splenectomy procedures were performed in 67 and 65 evaluable children, respectively. Surgical technique was not reported in two children. Overall immediate platelet response to splenectomy was achieved in 113 patients (86.3%). Eighty percent of responders maintained their status of response during the following 4 years. Older age, longer duration of ITP, and male gender correlated with a complete response. Post-splenectomy sepsis was reported in seven patients without lethal outcome, although sepsis might be differently defined at participating institutions. CONCLUSIONS: Splenectomy is effective in children with ITP. Management varies greatly in different institutions. These Registry data may serve as a basis for future clinical trials to assess the indication and timing of splenectomy.
机译:背景:脾切除术对患有严重或难治性特发性血小板减少性紫癜(ITP)的儿童和成人有效。有关儿科患者的数据有限。程序:来自25个国家/地区的57个机构的68个洲际儿童ITP研究小组(ICIS)的研究人员参加了脾切除手术登记册。提交了153例患者的数据,其中134例做了脾切除术并进行了分析。结果:脾切除术的中位年龄为11.8(2.7-20.7)岁。脾切除术的中位随访时间为2.0(0.1-4.5)年。脾切除术前未接种疫苗的21名儿童(15.7%)。分别对67例和65例可评估儿童进行了开放和腹腔镜脾切除术。尚无两个孩子的手术技术报道。 113名患者(86.3%)实现了对脾切除术的总体即刻血小板反应。在接下来的4年中,有80%的响应者保持了响应状态。年龄较大,ITP持续时间较长和男性性别与完全缓解相关。脾切除术后脓毒症有7例报告,没有致命的结局,尽管参与机构对脓毒症的定义有所不同。结论:脾切除术对ITP患儿有效。不同机构的管理差异很大。这些注册表数据可作为未来临床试验评估脾切除的指征和时机的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号